NLRP3 and pulmonary arterial hypertension: Numerous studies have demonstrated that Sil can significantly lower IL-18 levels of burned rat model heart tissue and that Sil treatment can lower NLRP3 expression in the lungs of animals with pulmonary hypertension.43